UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004376
Receipt number R000005229
Scientific Title The effect of glycolic acid peeling for acne vulgaris: a double-blind, randomized, left-right comparison study
Date of disclosure of the study information 2010/10/12
Last modified on 2013/04/16 09:37:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of glycolic acid peeling for acne vulgaris: a double-blind, randomized, left-right comparison study

Acronym

The effect of GA peeling for acne vulgaris

Scientific Title

The effect of glycolic acid peeling for acne vulgaris: a double-blind, randomized, left-right comparison study

Scientific Title:Acronym

The effect of GA peeling for acne vulgaris

Region

Japan


Condition

Condition

acne vulgaris

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of glycolic acid peeling for acne vulgaris

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

total acne lesion count at the end of treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Glycolic acid was applied to the skin lesions on the side of the face 5 times per 2weeks. plasebo was applied on the other side as a control.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients were required to have a minimum of 12 inflammatory facial lesions.

Key exclusion criteria

Wowen were excluded if they were pregnent, nursing, or planning a pregnancy.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuki Yamamoto

Organization

Wakayama Medical University

Division name

Depertment of Dermatology

Zip code


Address

811-1, Kimiidera, Wakayama City, Wakayama

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Wakayama Medical University

Division name

Depertment of Dermatology

Zip code


Address

811-1, Kimiidera, Wakayama City, Wakayama

TEL


Homepage URL


Email



Sponsor or person

Institute

Depertment of Dermatology, Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

Depertment of Dermatology, Wakayama Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 08 Month 26 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 12 Day

Last modified on

2013 Year 04 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005229


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name